小分子药物的化:棋盘上的新玩家
Cristina Morán-Serradilla1, Daniel Plano1, Carmen Sanmartín1
1Department of Pharmaceutical Sciences, University of Navarra, Irunlarrea 1, Pamplona E-31008, Spain.
Journal of medicinal chemistry
|May 8, 2024
概括
将 (Se) 纳入药物中,为开发新型治疗剂提供了一个有前途的战略,以打击耐药性并改善患者的治疗结果. 这项研究探讨了基于Se的药物开发的最新进展和未来潜力.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 越来越多的耐药性和副作用需要新的治疗方法.
- (Se) 在人类健康中起着至关重要的作用,它被纳入分子中显示出治疗的前景.
- 开发更安全,更有效的治疗方法是全球紧急的卫生优先事项.
研究的目的:
- 审查最近关于将分片纳入现有药物支架的文献.
- 探索这些新型含化合物的制药应用.
- 提供关于基药物研究未来方向,机遇和挑战的见解.
主要方法:
- 对将纳入药物分子的研究进行全面的文献综述.
- 报告的药物应用和治疗潜力的分析.
- 综合了当前进展和未来研究途径的观点.
主要成果:
- 许多研究表明,多种分片成功地集成到各种药物支架中.
- 这些新的改性药物在一系列病理中表现出有前途的治疗潜力.
- 加入可以提高疗效,并可能减少不良影响.
结论:
- 基于的药物开发是一个具有重大治疗前景的突破性领域.
- 对改性药物的进一步研究是有必要的,以解决未满足的医疗需求.
- 探索未来的方向,机遇和挑战将加速这些药物的临床转化.
相关概念视频
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
220
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
220
Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
Drug Metabolism: Phase II Reactions
3.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.8K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
200
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
200
Hepatic Drug Excretion: Influencing Factors
127
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
127
Phase II Reactions: Methylation Reactions
180
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
180


